<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30">
 <label>30.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Flammer</surname>
    <given-names>JR</given-names>
   </name>, 
   <name name-style="western">
    <surname>Dobrovolna</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kennedy</surname>
    <given-names>MA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chinenov</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Glass</surname>
    <given-names>CK</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ivashkiv</surname>
    <given-names>LB</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rogatsky</surname>
    <given-names>I</given-names>
   </name>
  </person-group>
  <year>2010</year>
  <article-title>The type I interferon signaling pathway is a target for glucocorticoid inhibition</article-title>. 
  <source>Mol Cell Biol</source>
  <volume>30</volume>:
  <fpage>4564</fpage>â€“
  <lpage>4574</lpage>. doi:
  <pub-id pub-id-type="doi">10.1128/MCB.00146-10</pub-id>.
  <pub-id pub-id-type="pmid">20679482</pub-id>
 </mixed-citation>
</ref>
